Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Cancer ; 74(7): 2412-2425, 2022.
Article in English | MEDLINE | ID: mdl-34854791

ABSTRACT

Colorectal cancer (CRC) is the third most common cancer worldwide with a high mortality rate. Dietary fibers, both soluble and insoluble, are essential for reducing the risk of CRC. In this study, a meta-analysis was performed to examine the relationship between the soluble and insoluble dietary fiber consumption and CRC risk. The highest vs. lowest fiber concentrations were compared by using PRISMA guidelines. To determine publishing bias, the Egger test; assess study heterogeneity I2 statistics were used. Studies that reported adjusted relative risk estimates with 95% confidence intervals (Cl) for the associations of interest were included. The results reveal that the relationship between soluble and insoluble fiber intake and the risk of CRC is almost equal [The total fiber ES = 0.75 (95% CI = 0.66-0.86), soluble fiber ES = 0.78 (95% CI = 0.66-0.92), insoluble fiber ES = 0.77 (95% CI = 0.67-0.88)]. Funnel plot and Egger's linear regression tests demonstrated that there was no publication bias. Both soluble and insoluble fiber consumption appear to be protective against CRC, with a clinically significant reduction in CRC risk. It is critical to identify preventive steps to avoid the CRC development, especially by leading a healthier lifestyle that includes healthy diet.


Subject(s)
Colorectal Neoplasms , Dietary Fiber , Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/prevention & control , Humans , Risk , Risk Factors
2.
J Breath Res ; 14(3): 036001, 2020 04 15.
Article in English | MEDLINE | ID: mdl-32031993

ABSTRACT

AIM: Lung adenocarcinoma is characterized by poor prognosis and short survival rates. Therefore, tools to identify the tumoural molecular structure and guide effective diagnosis and therapy decisions are essential. Surgical biopsies are highly invasive and not conducive for patient follow-up. To better understand disease prognosis, novel non-invasive analytic methods are needed. The aim of the present study is to identify the genetic mutations in formalin-fixed paraffin-embedded (FFPE) tissue, plasma, and exhaled breath condensate (EBC) samples by next-generation sequencing and evaluate their utility in the diagnosis and follow-up of patients with lung adenocarcinoma. METHOD: FFPE, plasma, and EBC samples were collected from 12 lung adenocarcinoma patients before treatment. DNA was extracted from the specimens using an Invitrogen PureLink Genomic DNA Kit according to the manufacturer's instructions. Amplicon-based sequencing was performed using Ion AmpliSeq Colon and Lung Cancer Research Panel v2. RESULTS: Genetic alterations were detected in all FFPE, plasma, and EBC specimens. The mutations in PIK3CA, MET, PTEN, SMAD4, and FGFR2 genes were highly correlated in six patients. Somatic and novel mutations detected in tissue and EBC samples were highly correlated in one additional patient. The EGFR p.L858R and KRAS p.G12C driver mutations were found in both the FFPE tissue specimens and the corresponding EBC samples of the lung adenocarcinoma patients. CONCLUSION: The driver mutations were detected in EBC samples from lung adenocarcinoma patients. The analysis of EBC samples represents a promising non-invasive method to detect mutations in lung cancer and guide diagnosis and follow-up.


Subject(s)
Breath Tests/methods , Exhalation , Lung Neoplasms/blood , Lung Neoplasms/genetics , Molecular Biology/methods , Adenocarcinoma of Lung/blood , Adenocarcinoma of Lung/genetics , Adult , Aged , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Mutation/genetics
3.
Oral Oncol ; 62: 90-100, 2016 11.
Article in English | MEDLINE | ID: mdl-27865377

ABSTRACT

BACKGROUND: Radiotherapy is one of the main treatment modalities for early-stage glottic carcinoma. Unfortunately, local failure may occur in a group of cases with T1-T2 glottic carcinoma. This meta-analysis sought to determine risk factors for radiation failure in patients with early-stage glottic carcinoma. METHODS: A systematic and comprehensive search was performed for related studies published between 1995 and 2014. The primary end-point was 5-year local control. Data extraction and analysis were performed using the software STATA/SE 13.1 for Windows. RESULTS: Twenty-seven studies were eligible. A higher risk of radiation failure was demonstrated in male patients [relative risk (RR): 0.927, p<0.001] and those with low hemoglobin level (RR: 0.891, p<0.001) with a high agreement between studies (I-squared=0.0%). Moreover, T2 tumors (RR: 0.795, p<0.001), tumors with anterior commissure involvement (RR: 0.904, p<0.001), tobacco use during/after therapy (RR: 0.824, p<0.001), and "bulky" tumors (RR: 1.270, p<0.001] or tumors bigger in size (RR: 1.332, p<0.001]. Poorly differentiated tumors had a questionable risk of local failure, although a moderate to high interstudy heterogeneity was determined. A statistically significant contribution was not detected for age, presence of comorbidity, alcohol use or subglottic extension. CONCLUSION: This is the first meta-analysis which assessed the potential risk factors for radiation failure in patients with early-stage glottic carcinoma. Gender and pretreatment hemoglobin level are major influential factors associated with radiation failure in patients with early-stage glottic carcinoma. However, prospective, randomized clinical trials may permit better stratification of their relative contributions, and those who may benefit more from upfront surgery.


Subject(s)
Glottis/pathology , Laryngeal Neoplasms/radiotherapy , Adult , Aged , Female , Humans , Male , Middle Aged , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...